SCHEMBL2834322

SCHEMBL2834322

Cc1ccc(-c2[c]ccc(-c3ccc(C)cc3)c2-c2ccc(C)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.35
PTGS1 P23219 1/20 0.34
ACHE P22303 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
HEXA P06865 1/20 0.32
HEXB P07686 1/20 0.32
ENPP1 P22413 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28506113 0.82 ACHE (0.33) PTGS2ACHETDP1HEXAHEXB
SCHEMBL9559530 0.80 PTGS2 (0.36) PTGS2PTGS1ENPP1
SCHEMBL1812352 0.80 ESR1 (0.39)
SCHEMBL891578 0.79 LMNA (0.36)
SCHEMBL7705602 0.76 ACHE (0.35) ACHETDP1
SCHEMBL7702892 0.76 TSHR (0.34) PTGS2PTGS1
SCHEMBL8478136 0.76 HEXA (0.39) PTGS2PTGS1HEXAHEXB
SCHEMBL9559721 0.74 ADORA1 (0.36) PTGS2PTGS1ACHE
SCHEMBL7705609 0.73 MEN1 (0.33) ACHETDP1ENPP1
SCHEMBL8478421 0.73 ALDH1A1 (0.36) PTGS2PTGS1HEXAHEXB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114206886-A Luminescent gold (III) compound, method for preparing same, and organic light emitting device using same 广东聚华印刷显示技术有限公司 2022-03-18 CN claimed
US-8436344-B2 Organic electroluminescent device LG DISPLAY CO., LTD. (KR) 2013-05-07 US claimed
US-20100155714-A1 ORGANIC ELECTROLUMINESCENT DEVICE LG DISPLAY CO., LTD. (KR) 2010-06-24 US claimed
US-7700201-B2 Organic electroluminescent device LG DISPLAY CO., LTD. (KR) 2010-04-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100155714-A1 ORGANIC ELECTROLUMINESCENT DEVICE L1CAM, AOC2, AOC1 PTGS2 2622/4885PTGS1 3594/4885ACHE 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.